Tsopra, Rosy https://orcid.org/0000-0002-9406-5547
Fernandez, Xose
Luchinat, Claudio
Alberghina, Lilia
Lehrach, Hans
Vanoni, Marco
Dreher, Felix
Sezerman, O.Ugur
Cuggia, Marc
de Tayrac, Marie
Miklasevics, Edvins
Itu, Lucian Mihai
Geanta, Marius
Ogilvie, Lesley
Godey, Florence
Boldisor, Cristian Nicolae
Campillo-Gimenez, Boris
Cioroboiu, Cosmina
Ciusdel, Costin Florian
Coman, Simona
Hijano Cubelos, Oliver
Itu, Alina
Lange, Bodo
Le Gallo, Matthieu
Lespagnol, Alexandra
Mauri, Giancarlo
Soykam, H.Okan
Rance, Bastien
Turano, Paola
Tenori, Leonardo
Vignoli, Alessia
Wierling, Christoph
Benhabiles, Nora
Burgun, Anita
Funding for this research was provided by:
This work was supported by the ITFoC project (Information Technology for the Future of Cancer) – FLAG-ERA support.
Article History
Received: 18 June 2020
Accepted: 22 September 2021
First Online: 2 October 2021
Declarations
:
: Not applicable.
: Not applicable.
: Hans Lehrach is a member of the board of Alacris Theranostics GmbH. Felix Dreher is an employee of Alacris Theranostics GmbH. Lesley Ogilvie is an employee of Alacris Theranostics GmbH. Bodo Lange is the CEO of Alacris Theranostics GmbH. Christoph Wierling is an employee of Alacris Theranostics GmbH. The other authors have no conflicts of interest to declare.